second-line - Globe Thesis

Keyword [second-line] Result: 81 - 100 \| Page: 5 of 7
81.	The Systematic Review Of Pemetrexed Versus Docetaxel In Second-line Chemotherapy With Non-small Cell Lung Cancer
82.	Analysis Of Efficacy And Safety Baesd On Varied Second-line Treatments And Prognosis Factors Of Relapsed Small Cell Lung Cancer
83.	Analysis Of Second-Line Anti-Tuberculosis Drug Resistance Characteristics And Associated-Genes Of Clinical Mycobacterium Tuberculosis Isolates From Hebei Province
84.	Clinical Study Of Second-line Treatment Of Advanced Gastrointestinal Stromal Tumor With Sunitinib Malate (Analysis Of 37 Cases)
85.	Clinical Observation Of Traditional Chinese Medicine Combined With Apatinib For Advanced Gastric Cancer Patients With Second-line And Above Chemotherapy Failure
86.	Comparatives Tudy Of Second-line Treatment Of Advanced Colorectal Cancer With TOMIRI And FOLFIRI Regimen
87.	Efficacy Of Double-Drug And Single-Drug Chemotherapy In Second-Line Treatment Of Advanced Gastric Cancer
88.	Efficacy Of Bevacizumab Combined With Chemotherapy As First-line And Second-line Treatment In Metastatic Colorectal Cancer
89.	Second-line Drug Selection For Adult Autoimmune Hepatitis:A Systematic Review And Meta-analysis
90.	Clinical Efficacy Of Apatinib In Second-line Treatment Failure Of Extensive Stage Small Cell Lung Cancer
91.	The Retrospective Study Of Anlotinib In Second-line And Above Treatment For Advanced Lung Squamous Cell Carcinoma
92.	Clinical Observation Of Apatinib In The Treatment Of Patients With Recurrent Or Metastatic Cervical Cancer As Second-line Drug
93.	Clinical Analysis Of Anti-N-Methyl-D-Aspartate Receptor Encephalitis In Adults And Children
94.	Apatinib Plus S-1 As Second-line Or Above-line Treatment For Advanced Lung Squamous Cell Carcinoma:A Phase Ⅱ,Single-arm,Multicentre,Prospective Study
95.	The Evolution Of HIV Under Long-term Antiviral Therapy And The Therapeutic Effect After Replacing Second-line Drugs
96.	Clinical Efficacy And Analysis Of Safety Of Anlotinib In Treatment Of Second-line And Above Small Cell Lung Cancer
97.	A Retrospective Multicenter Study Of A Combination Of S-1 And Non-platinum-based Chemotherapy As Second-line Therapy For Advanced Non-small Cell Lung Cancer Patients
98.	Prospective Study Of Apatinib Combined With Chemotherapy In The Treatment Of Second-line Or Above Advanced Small Cell Lung Cancer
99.	Efficacyandsafetyofsecond-lineirinotecancombinedwith Anlotinibinthetreatmentofsmallcelllungcancer
100.	Clinical Observation Of Anlotinib Combined With Docetaxel In The Treatment Of Advanced Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to